Journal Information
Vol. 45. Issue 9.
Pages 419-421 (September 2009)
Vol. 45. Issue 9.
Pages 419-421 (September 2009)
Editorial
Full text access
Again an asthma model: but a useful one
Visits
4410
a Pharmacology, Therapeutics and Toxicology Department, Autonomous University of Barcelona, Barcelona, Spain
b Respiratory Immunoallergy Clinical and Experimental Laboratory, IDIBAPS, Clinical Hospital, Barcelona, Spain
c Respiratory Disease Network Biomedical Research Centre (CIBERes), Barcelona, Spain
d Department of Medicine, Respiratory Allergies and Pneumology, Clinical Hospital, University of Barcelona, Barcelona, Spain
This item has received
Article information
Full text is only aviable in PDF
References
[1.]
R. Fraga-Iriso, L. Núnez-Naveira, N.S. Brienza, A. Centeno-Cortés, E. López-Peláez, H. Verea, et al.
Desarrollo de un modelo murino de inflamación y remodelación de vías respiratorias en asma experimental.
Arch Bronconeumol, (2009),
[2.]
S. Wenzel, S.T. Holgate.
The mouse trap: it still yields few answers in asthma.
Am J Respir Crit Care Med, 174 (2006), pp. 1173-1176
[3.]
C.M. Lloyd.
Building better mouse models of asthma.
Curr Allergy Asthma Rep, 7 (2007), pp. 231-236
[4.]
J. Cortijo Gimeno.
Modelos experimentales de asma. Aportaciones y limitaciones.
Arch Bronconeumol, 39 (2003), pp. 54-56
[5.]
R. Torres, C. Picado, F. De Mora.
Descubriendo el asma de origen alérgico a través del ratón. Un repaso a la patogenia de los modelos de asma alérgica en el ratón y su similitud con el asma alérgica humana.
Arch Bronconeumol, 41 (2005), pp. 141-152
[6.]
E. López, V. Del Pozo, T. Miguel, B. Sastre, C. Seoane, E. Civantos, et al.
Inhibition of chronic airway inflammation and remodeling by galectin-3gene therapy in a murine model.
J Immunol, 176 (2006), pp. 1943-1950
[7.]
J. Temelkovski, S.P. Hogan, D.P. Shepherd, P.S. Foster, R.K. Kumar.
An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aero-solised allergen.
Thorax, 53 (1998), pp. 849-856
[8.]
S.J. McMillan, C.M. Lloyd.
Prolonged allergen challenge in mice leads to persistent airway remodelling.
Clin Exp Allergy, 34 (2004), pp. 497-507
[9.]
M. Yu, M. Tsai, S.Y. Tam, C. Jones, J. Zehnder, S.J. Galli.
Mast cells can promote the development of multiple features of chronic asthma in mice.
J Clin Invest, 116 (2006), pp. 1633-1641
[10.]
J.R. Johnson, R.E. Wiley, R. Fattouh, F.K. Swirski, B.U. Gajewska, A.J. Coyle, et al.
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling.
Am J Respir Crit Care Med, 169 (2004), pp. 378-385
[11.]
L. Conejero, Y. Higaki, M.L. Baeza, M. Fernández, I. Varela-Nieto, J.M. Zubeldia.
Pollen-induced airway inflammation, hyper-responsiveness and apoptosis in a murine model of allergy.
Clin Exp Allergy, 37 (2007), pp. 331-338
[12.]
R. Torres, M. Pérez, A. Marco, C. Picado, F. De Mora.
Un inhibidor selectivo de la ciclooxigenasa-2 empeora la función respiratoria y fomenta la actividad de los mastocitos en ratones sensibilizados a la ovalbúmina.
Arch Bronconeumol, 45 (2009), pp. 162-167
[13.]
A. Herrerías, R. Torres, M. Serra, A. Marco, J. Roca-Ferrer, C. Picado, et al.
Subcutaneous prostaglandin E(2) restrains airway mast cell activity in vivo and reduces lung eosinophilia and Th(2) cytokine overproduction in house dust mite-sensitive mice.
Int Arch Allergy Immunol, 149 (2009), pp. 323-332
[14.]
S. Siddiqui, F. Hollins, S. Saha, C.E. Brightling.
Inflammatory cell microlocalisation and airway dysfunction: cause and effect?.
Eur Respir J, 30 (2007), pp. 1043-1056
[15.]
A.E. Dixon.
Rhinosinusitis and asthma: the missing link.
Curr Opin Pulm Med, 15 (2009), pp. 19-24
Copyright © 2009. Sociedad Española de Neumología y Cirugía Torácica